Your browser doesn't support javascript.
loading
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022.
Ascierto, Paolo A; Brentjens, Renier; Khleif, Samir N; Odunsi, Kunle; Rezvani, Katayoun; Ruella, Marco; Sullivan, Ryan J; Fox, Bernard A; Puzanov, Igor.
Affiliation
  • Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy. paolo.ascierto@gmail.com.
  • Brentjens R; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Khleif SN; The Loop Immuno Oncology Laboratory, Georgetown University Medical School, Washington, DC, USA.
  • Odunsi K; University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL, USA.
  • Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ruella M; Center for Cellular Immunotherapies and Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • Sullivan RJ; Melanoma Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Fox BA; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA.
  • Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
J Transl Med ; 21(1): 275, 2023 04 22.
Article in En | MEDLINE | ID: mdl-37087493
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunotherapy / Neoplasms Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunotherapy / Neoplasms Limits: Humans Language: En Year: 2023 Type: Article